ici 118551 has been researched along with clenbuterol in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (25.81) | 18.7374 |
| 1990's | 10 (32.26) | 18.2507 |
| 2000's | 7 (22.58) | 29.6817 |
| 2010's | 5 (16.13) | 24.3611 |
| 2020's | 1 (3.23) | 2.80 |
| Authors | Studies |
|---|---|
| Droux, S; Kern, C; Meyer, T; Miculka, C; Schollmeyer, D | 1 |
| Lindsay, DB; Matthews, ML; Pegg, GG; Sillence, MN; Spiers, WG | 1 |
| Berrow, NS; Lacey, RJ; Morgan, NG; Scarpello, JH | 1 |
| O'Donnell, JM | 1 |
| Akahane, K; Chiba, S; Furukawa, Y; Haniuda, M; Ogiwara, Y | 1 |
| Armando, I; Enero, MA; Gutkind, JS; Kazanietz, MG; Puyo, A | 1 |
| Edwards, DJ; Knopf, S; Sorisio, DA | 1 |
| Beer, M; Iversen, LL; Poat, J; Richardson, A; Stahl, SM | 1 |
| Brunswick, DJ; Conway, PG; Tondo, L | 1 |
| Frazer, A; O'Donnell, J; Ordway, G; Vos, P; Wolfe, B | 1 |
| Frazer, A; O'Donnell, JM; Ordway, GA | 1 |
| Francès, H; Simon, P | 1 |
| Badran, TW; Hoey, AJ; Matthews, ML; Pegg, GG; Sillence, MN | 1 |
| Matthews, ML; Moore, NG; Reich, MM; Sillence, MN | 1 |
| Cartañà, J; Stock, MJ | 1 |
| Frith, S; O'Donnell, JM; Wilkins, J | 1 |
| Blackburn, SJ; Brocklehurst, KJ; Holloway, BR; Thorpe, KA; Waddell, ID | 1 |
| Feller, DR; Konkar, AA; Lezama, EJ; Miller, DD; Salazar-Bookaman, MM | 1 |
| Agbenyega, ET; Hatton, PA; Morton, RH; Wareham, AC | 1 |
| Elliott, RA; Hudman, D; Norman, RI | 1 |
| Fischer, W; Kittner, H; Malinowska, B; Regenthal, R; Schlicker, E | 1 |
| Liang, W; Mills, S | 1 |
| Kettelhut, IC; Machado, CR; Migliorini, RH; Navegantes, LC; Resano, NM | 1 |
| Denda, M; Fuziwara, S; Inoue, K | 1 |
| Abukhalaf, IK; Dutt, K; Klement, BJ; Mitchell, CD; Silvestrov, NA; von Deutsch, AW; von Deutsch, DA; Williams, CE | 1 |
| Lu, RC; Miao, D; Tan, L; Tian, Y; Wang, ND; Wang, XX; Yu, JT; Yu, NN | 1 |
| Kalivas, PW; LaLumiere, RT; Niehoff, KE | 1 |
| Ha, TN; Head, SI | 1 |
| Cambron, M; De Keyser, J; Demol, F; Kooijman, R; Laureys, G; Muscat, R; Valentino, M; Zammit, C | 1 |
| Batchelor, HN; Bidlack, JM; Brown, E; Dawes, RP; Lordy, KA; Majewska, AK; Sipe, GO; Stoessel, MB; Stowell, RD; Sur, M; Whitelaw, BS | 1 |
| Arjmand, B; Dehpour, AR; Gharaylou, Z; Hadjighassem, M; Hashemizadeh, S; Hosseindoost, S; Javadi, SAH | 1 |
31 other study(ies) available for ici 118551 and clenbuterol
| Article | Year |
|---|---|
Synthesis and pharmacological characterization of beta2-adrenergic agonist enantiomers: zilpaterol.
Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Chromatography, High Pressure Liquid; Crystallography, X-Ray; Humans; Recombinant Proteins; Stereoisomerism; Trimethylsilyl Compounds | 2009 |
Effects of clenbuterol, ICI118551 and sotalol on the growth of cardiac and skeletal muscle and on beta 2-adrenoceptor density in female rats.
Topics: Adrenergic beta-Antagonists; Animals; Clenbuterol; Eating; Female; Heart; Hindlimb; Iodine Radioisotopes; Iodocyanopindolol; Muscle Development; Muscles; Myocardium; Organ Size; Pindolol; Propanolamines; Rats; Receptors, Adrenergic, beta; Sotalol | 1991 |
Selective stimulation of glucagon secretion by beta 2-adrenoceptors in isolated islets of Langerhans of the rat.
Topics: 1-Methyl-3-isobutylxanthine; Adrenergic beta-Antagonists; Animals; Atenolol; Clenbuterol; Colforsin; Cyclic AMP; Glucagon; In Vitro Techniques; Insulin; Islets of Langerhans; Male; Propanolamines; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta | 1991 |
Behavioral effects of beta adrenergic agonists and antidepressant drugs after down-regulation of beta-2 adrenergic receptors by clenbuterol.
Topics: Adrenergic beta-Agonists; Animals; Antidepressive Agents; Benzimidazoles; Clenbuterol; Conditioning, Operant; Desipramine; Dobutamine; Down-Regulation; Ethanolamines; Male; Prenalterol; Propanolamines; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta | 1990 |
Beta-adrenoceptor blocking effects of a selective beta 2-agonist, mabuterol, on the isolated, blood-perfused right atrium of the dog.
Topics: 1-Methyl-3-isobutylxanthine; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Atenolol; Calcium Chloride; Clenbuterol; Dobutamine; Dogs; Ethanolamines; Heart; Heart Rate; In Vitro Techniques; Isoproterenol; Myocardial Contraction; Procaterol; Propanolamines | 1989 |
Further evidence of interaction between vasodilator beta 2- and vasoconstrictor alpha 2-adrenoceptor-mediated responses in maintaining vascular tone in anesthetized rats.
Topics: Anesthesia; Animals; Blood Pressure; Catecholamines; Clenbuterol; Heart Rate; Isoproterenol; Male; Muscle Tonus; Muscle, Smooth, Vascular; Propanolamines; Rats; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Vasoconstriction; Vasodilation | 1989 |
Effects of the beta 2-adrenoceptor agonist clenbuterol on tyrosine and tryptophan in plasma and brain of the rat.
Topics: Amino Acids; Animals; Betaxolol; Brain Chemistry; Clenbuterol; Dose-Response Relationship, Drug; Ethanolamines; Male; Methysergide; Propanolamines; Propranolol; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta; Tryptophan; Tyrosine | 1989 |
In vitro selectivity of agonists and antagonists for beta 1- and beta 2-adrenoceptor subtypes in rat brain.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Binding Sites; Brain Chemistry; Cerebral Cortex; Clenbuterol; Imidazoles; In Vitro Techniques; Male; Pindolol; Propanolamines; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta; Stereoisomerism | 1988 |
Labeling in vivo of beta adrenergic receptors in the central nervous system of the rat after administration of [125I] iodopindolol.
Topics: Alprenolol; Animals; Betaxolol; Binding, Competitive; Brain Stem; Central Nervous System; Cerebellum; Cerebral Cortex; Clenbuterol; Isotope Labeling; Male; Mathematics; Pindolol; Propanolamines; Propranolol; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta; Spinal Cord; Tissue Distribution | 1985 |
Effect of repeated administration of clenbuterol on the regulation of beta-adrenoceptors in the central nervous system of the rat.
Topics: Animals; Brain; Cerebellum; Cerebral Cortex; Clenbuterol; Cyclic AMP; Ethanolamines; Isoproterenol; Kinetics; Propanolamines; Rats; Receptors, Adrenergic, beta | 1986 |
Effects of clenbuterol on central beta-1 and beta-2 adrenergic receptors of the rat.
Topics: Animals; Cerebellum; Cerebral Cortex; Clenbuterol; Cyclic AMP; Ethanolamines; Isoproterenol; Pindolol; Propanolamines; Rats; Receptors, Adrenergic, beta | 1987 |
Reserpine-induced hypothermia: participation of beta 1 and beta 2 adrenergic receptors.
Topics: Animals; Betaxolol; Body Temperature; Clenbuterol; Dobutamine; Ethanolamines; Male; Mice; Propanolamines; Receptors, Adrenergic, beta; Reserpine | 1987 |
Cardiovascular effects of clenbuterol are beta 2-adrenoceptor-mediated in steers.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Atrial Function; Blood Glucose; Blood Pressure; Cardiovascular Physiological Phenomena; Cardiovascular System; Cattle; Clenbuterol; Dose-Response Relationship, Drug; Heart Atria; Heart Rate; Imidazoles; Infusions, Intravenous; Isoproterenol; Male; Norepinephrine; Potassium; Propanolamines; Rats; Rats, Wistar; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2 | 1995 |
Effects of BRL-47672 on growth, beta 2-adrenoceptors, and adenylyl cyclase activation in female rats.
Topics: Adenylyl Cyclases; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Binding, Competitive; Clenbuterol; Enzyme Activation; Female; Growth; Imidazoles; Organic Chemicals; Propanolamines; Rats; Receptors, Adrenergic, beta; Second Messenger Systems | 1995 |
Effects of clenbuterol and salbutamol on tissue rubidium uptake in vivo.
Topics: Adipose Tissue, Brown; Adrenergic beta-Antagonists; Albuterol; Animals; Body Weight; Clenbuterol; Male; Muscle, Skeletal; Organ Size; Propanolamines; Rats; Rats, Wistar; Rubidium; Time Factors | 1995 |
Involvement of beta-1 and beta-2 adrenergic receptors in the antidepressant-like effects of centrally administered isoproterenol.
Topics: Animals; Antidepressive Agents; Betaxolol; Clenbuterol; Isoproterenol; Male; Propanolamines; Propranolol; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Reinforcement, Psychology | 1994 |
Anabolic effects of a range of beta 2-adrenoceptor agonists in a clonal G8.P8 cell line.
Topics: Actins; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Animals; Cell Line; Clenbuterol; Kinetics; Muscle, Skeletal; Prenalterol; Propanolamines; Rats; Time Factors; Tropomyosin; Troponin; Troponin T | 1996 |
Pharmacological study of atypical beta-adrenoceptors in rat esophageal smooth muscle.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Carbachol; Clenbuterol; Cyclohexane Monoterpenes; Esophagus; Ethanolamines; Female; Heart Atria; In Vitro Techniques; Isoproterenol; Male; Muscle Relaxation; Muscle, Smooth; Phenethylamines; Phenoxyacetates; Phenoxypropanolamines; Pindolol; Propanolamines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta; Serotonin Antagonists; Trachea; Tretoquinol | 1996 |
Effects of clenbuterol and ICI118551, a selective beta 2-antagonist, on the growth of skeletal muscle of suckling rats.
Topics: Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Animals, Suckling; Body Weight; Clenbuterol; Eating; Female; Lactation; Male; Muscle Development; Muscle Proteins; Muscle, Skeletal; Organ Size; Propanolamines; Rats; Rats, Sprague-Dawley | 1995 |
Inhibition of the contractile response of the rat detrusor muscle by the beta(2)-adrenoceptor agonist clenbuterol.
Topics: Adenosine Triphosphate; Adrenergic beta-Agonists; Animals; Carbachol; Clenbuterol; Electric Stimulation; Female; In Vitro Techniques; Male; Muscle Contraction; Propanolamines; Rats; Rats, Wistar; Receptors, Adrenergic, beta-2; Tetrodotoxin; Urinary Bladder | 2000 |
Anticonvulsant and sodium channel blocking activity of higher doses of clenbuterol.
Topics: Adrenergic beta-Agonists; Animals; Anticonvulsants; Clenbuterol; Electroshock; Female; Hippocampus; Male; Mice; Propanolamines; Rats; Rats, Wistar; Seizures; Sodium Channels; Stereoisomerism | 2001 |
Profile of ligand binding to the porcine beta2-adrenergic receptor.
Topics: Animals; Binding, Competitive; CHO Cells; Clenbuterol; Cricetinae; Epinephrine; Ethanolamines; Guanylyl Imidodiphosphate; Humans; Iodocyanopindolol; Kinetics; Ligands; Phenethylamines; Propanolamines; Propranolol; Pyridines; Receptors, Adrenergic, beta-2; Signal Transduction; Swine | 2001 |
Beta2-agonists and cAMP inhibit protein degradation in isolated chick (Gallus domesticus) skeletal muscle.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Bucladesine; Chickens; Clenbuterol; Epinephrine; Kinetics; Muscle Proteins; Muscle, Skeletal; Propanolamines; Receptors, Adrenergic, beta-2 | 2003 |
Beta2-adrenergic receptor antagonist accelerates skin barrier recovery and reduces epidermal hyperplasia induced by barrier disruption.
Topics: Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Alprenolol; Animals; Biological Transport; Calcium; Calcium Channel Blockers; Calcium Channels; Clenbuterol; Epidermis; Humidity; Hyperplasia; Male; Mice; Mice, Hairless; Nifedipine; Procaterol; Propanolamines; Verapamil | 2003 |
Polyamines protect against radiation-induced oxidative stress.
Topics: Adrenergic beta-Agonists; Catalase; Cell Line, Transformed; Cell Survival; Clenbuterol; Culture Media; Eflornithine; Enzyme Inhibitors; Free Radical Scavengers; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Humans; Membrane Proteins; Ornithine Decarboxylase; Oxidative Stress; Polyamines; Propanolamines; Reactive Oxygen Species; Retina; Superoxide Dismutase; Ultraviolet Rays | 2005 |
Blocking beta2-adrenergic receptor attenuates acute stress-induced amyloid beta peptides production.
Topics: Acute Disease; Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Alzheimer Disease; Amyloid beta-Peptides; Animals; Clenbuterol; Disease Models, Animal; Hippocampus; Male; Mice; Mice, Inbred C57BL; Peptide Fragments; Propanolamines; Proto-Oncogene Proteins c-fos; Random Allocation; Receptors, Adrenergic, beta-2; Restraint, Physical; RNA, Messenger; Stress, Psychological | 2010 |
The infralimbic cortex regulates the consolidation of extinction after cocaine self-administration.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Analysis of Variance; Animals; Baclofen; Behavior, Animal; Bicuculline; Clenbuterol; Cocaine; Conditioning, Operant; Dopamine Uptake Inhibitors; Extinction, Psychological; Food Deprivation; Frontal Lobe; GABA Agonists; GABA Antagonists; Male; Microinjections; Muscimol; Phenoxyacetates; Propanolamines; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology; Self Administration; Time Factors | 2010 |
Acute inhibitory effects of clenbuterol on force, Ca²⁺ transients and action potentials in rat soleus may not involve the β₂-adrenoceptor pathway.
Topics: Action Potentials; Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-Agonists; Animals; Calcium; Clenbuterol; Indoles; Male; Muscle Contraction; Muscle Fibers, Skeletal; Muscle Strength; Potassium; Propanolamines; Rats; Rats, Wistar; Receptors, Adrenergic, beta-2 | 2011 |
β₂-adrenergic receptors protect axons during energetic stress but do not influence basal glio-axonal lactate shuttling in mouse white matter.
Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-2 Receptor Antagonists; Animals; Axons; Central Nervous System Agents; Cerebellum; Clenbuterol; Corpus Callosum; Coumaric Acids; Glutamic Acid; Lactic Acid; Male; Mice, Inbred C57BL; Neuroglia; Propanolamines; Receptors, Adrenergic, beta-2; Stress, Physiological; White Matter | 2014 |
Noradrenergic signaling in the wakeful state inhibits microglial surveillance and synaptic plasticity in the mouse visual cortex.
Topics: Animals; Benzylamines; Cell Movement; Circadian Rhythm; Clenbuterol; CX3C Chemokine Receptor 1; Dexmedetomidine; Dominance, Ocular; Female; Fentanyl; Locus Coeruleus; Male; Mice; Mice, Transgenic; Microglia; Nadolol; Neuronal Plasticity; Neurons; Norepinephrine; Propanolamines; Restraint, Physical; Terbutaline; Visual Cortex; Wakefulness; Wounds and Injuries | 2019 |
β2-Adrenergic Receptor Stimulation Upregulates Cx43 Expression on Glioblastoma Multiforme and Olfactory Ensheathing Cells.
Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-2 Receptor Antagonists; Astrocytes; Brain Neoplasms; Cells, Cultured; Clenbuterol; Connexin 43; Glioblastoma; Humans; Olfactory Receptor Neurons; Propanolamines; Tumor Cells, Cultured; Up-Regulation | 2020 |